Journal list menu
Alzheimer's & Dementia
Editor-in-Chief: Zaven S. Khachaturian, PhD
Executive Editor: Ara S. Khachaturian, PhD
About the Journal
Alzheimer’s & Dementia® aims to bridge the knowledge gaps across a wide range of bench-to-bedside investigation in dementia and Alzheimer's Disease.
Article featured in the August issue of Alzheimer’s & Dementia:
- COVID-19 and dementia: Analyses of risk, disparity, and outcomes from electronic health records in the US
- Plasma p-tau181, p-tau217, and other blood-based Alzheimer's disease biomarkers in a multi-ethnic, community study
- Deepen into sleep and wake patterns across Alzheimer's disease phenotypes
- Association of life-course depression with the risk of dementia in late life: A nationwide twin study
Article featured in the September issue of Alzheimer’s & Dementia:
- Head injury and 25-year risk of dementia
- Investigating the association between cancer and the risk of dementia: Results from the Memento cohort
- Replication study of plasma proteins relating to Alzheimer's pathology
- Midlife vascular risk factors and risk of incident dementia: Longitudinal cohort and Mendelian randomization analyses in the UK Biobank
Article featured in the October issue of Alzheimer’s & Dementia:
- Associations of loneliness with risk of Alzheimer's disease dementia in the Framingham Heart Study
- Early prevention of cognitive impairment in the community population: The Beijing Aging Brain Rejuvenation Initiative
- Functional decline in the aphasic variant of Alzheimer's disease
- Quantifying progression in primary progressive aphasia with structural neuroimaging
Articles
The epidemiology is promising, but the trial evidence is weak. Why pharmacological dementia risk reduction trials haven't lived up to expectations, and where do we go from here?
- 2 November 2021
Neuropsychological, neuropsychiatric, and quality‐of‐life assessments in Alzheimer's disease patients treated with plasma exchange with albumin replacement from the randomized AMBAR study
- 2 November 2021
The following is a list of the most cited articles based on citations published in the last three years, according to CrossRef.
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
- 263-269
- 22 April 2011
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
- 535-562
- 1 April 2018
The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
- 270-279
- 22 April 2011
The chronic neuropsychiatric sequelae of COVID‐19: The need for a prospective study of viral impact on brain functioning
- Alzheimer's & Dementia
- 1056-1065
- 5 January 2021
Failure to demonstrate efficacy of aducanumab: An analysis of the EMERGE and ENGAGE trials as reported by Biogen, December 2019
- Alzheimer's & Dementia
- 696-701
- 1 November 2020
COVID‐19 and dementia: Analyses of risk, disparity, and outcomes from electronic health records in the US
- Alzheimer's & Dementia
- 1297-1306
- 9 February 2021
Altmetric measures the online attention that an article receives. Click here to view the latest trending articles from Alzheimer’s & Dementia based on attention in the past week.
The list below shows the top 3 Alzheimer’s & Dementia articles based on all-time Altmetric scores:
Recent issues
Latest news
Stay Connected with the Alzheimer’s Association®
The Alzheimer’s Association® advances research to end Alzheimer’s and dementia while enhancing care for those living with the diseases. The Alzheimer’s Association is the largest non-profit funder of Alzheimer’s disease research. Its mission is “to eliminate Alzheimer’s disease through the advancement of research; to provide and enhance care and support for all affected; and to reduce the risk of dementia through the promotion of brain health”.
- ISTAART
- AAIC Conference
- International Grant Program
- TrialMatch
- Research Program
- About the Association
Follow the Alzheimer’s Association®:
Published on behalf of the
Search articles from all three publications, and keep up with the latest information on the Alzheimer's Association® journal hub page.
Go to the society hub >>
Companion Journals
Read the 2021 Alzheimer's disease facts and figures HERE
View the infographic HERE
ALZHEIMER'S DRUG DEVELOPMENT & FUNDING
Read the 2021 Alzheimer's Disease Drug Development Pipeline HEREView the infographic HERE
- Virtual Issue: World Wide FINGERS Publications
- Special Topic Issue: Psychosocial Measures
- Special Topic Section: Alzheimer's Disease Among Adults with Down Syndrome
Calls for Papers
- Call for Papers: TRCI Special Topic Issue: Psychosocial Measures
- Call for Papers: DADM Special Topic Section: Cognitive Decline, Mild Cognitive Impairment, Alzheimer’s disease and related dementias among Latinos
- Call for Papers: DADM Special Topic Section: Digital Biomarkers for Alzheimer Disease and Related Dementias
- Call for Papers: DADM Special Topic Section: Synergistic effects of both individual differences and modifiable risk factors on AD progression
Stay Connected with the Alzheimer's Association ®
The Alzheimer’s Association® advances research to end Alzheimer’s and dementia while enhancing care for those living with the diseases. The Alzheimer’s Association is the largest non-profit funder of Alzheimer’s disease research. Its mission is “to eliminate Alzheimer’s disease through the advancement of research; to provide and enhance care and support for all affected; and to reduce the risk of dementia through the promotion of brain health”.
- ISTAART
- AAIC Conference
- International Grant Program
- TrialMatch
- Research Program
- About the Association
Follow the Alzheimer’s Association®:
